Heart Arrhythmia
9
3
5
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
Ablation of Consecutive Atrial Tachycardia
AB-1002 in Patients With Class III Heart Failure
The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)
Acu Tens Versus Low Level Laser After Open Heart Surgeries
Effects of Switching From Racemic Methadone to R-methadone on QTc Intervals
ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing
Transcutaneous Electrical Stimulation & Sinoatrial Node Function
Feasibility Study of the µCor Heart Failure and Arrhythmia Management System (PATCH)
Stereotactic Radioablation for the Treatment of Refractory Atrial Fibrillation